---
schema_version: "secwatch.filing_event.v1"
accession: "0001699350-26-000054"
form_type: "8-K"
ticker: "SI"
cik: "0001699350"
company_name: "SHOULDER INNOVATIONS, INC."
filed_at: "2026-08-10T11:09:48+00:00"
generated_at: "2026-08-10T11:15:25.488101+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Shoulder Innovations promotes Jon Osborne to Chief Commercial Officer

## Summary
- Jon Osborne promoted to Chief Commercial Officer, effective Aug 6, 2026; previously VP of Commercial Development.
- Osborne joined Shoulder Innovations in Sept 2023; prior 9 years at Smith & Nephew, most recently VP Commercial Marketing for Sports Medicine.
- New role covers all commercial organization, customer experience, and medical education teams.
- CEO Rob Ball cites Osborne's role in go-to-market strategy and scaling adoption.

## SEC filing metadata
- accession: 0001699350-26-000054
- form_type: 8-K
- ticker: SI
- cik: 0001699350
- company_name: SHOULDER INNOVATIONS, INC.
- filed_at: 2026-08-10T11:09:48+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/0001699350-26-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/si-20260810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001699350-26-000054
- JSON: https://secwatch.observer/filing/0001699350-26-000054.json
- Plain text: https://secwatch.observer/filing/0001699350-26-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.